Why Yale Urology
At Yale Urology, we understand the physical and emotional toll any form of cancer takes on patients and their families, and leave you and your loved ones with many questions about the journey ahead. Our team members are dedicated to providing the compassionate care, support, and information you need to move forward confidently with your treatment process.
We are committed to offering our patients with early- and late-stage testicular cancer the most advanced diagnostic technologies and treatment strategies available.
Yale Urology offers a full slate of advanced medical and surgical procedures to address testicular cancer. Surgical removal of a malignant testicle is the most common treatment, with no impact on sexual performance or the ability to father children. Radiation or chemotherapy may be preferred for some cases. All treatment is provided at the state-of-the-art Smilow Cancer Hospital.
Our surgeons are at the forefront of research for many types of cancer, pointing the way to new treatments. We continually integrate the latest in science-based medicine and innovative approaches into our practice to offer patients safer and more effective treatments.
About Testicular Cancer
Testicular cancer is a disease in which cells in the male testes (the sperm-producing glands inside the scrotum) become malignant. Testicular cancer is rare – only about 8,000 new cases are diagnosed each year – but it is also the most common cancer among 15- to 34-year-old men in the U.S.
Testicular cancer is highly treatable, with more than 95 percent of patients cured. Regular self-examinations can help identify problems early on, increasing the likelihood of successful treatment.
Additional information about testicular cancer:
- Testicular Cancer Treatment
- Testicular Cancer Screening
- Extragonadal Tumors Treatment
- Penile Cancer Treatment